Diagnostic pathology of lymphoproliferative disorders.
The last 20 years have seen a dramatic change in the way we classify, and therefore diagnose, lymphoma. Two decades ago, the International Working Formulation enabled diagnosis and management on the basis of H&E sections alone, with no mandatory requirement for immunophenotyping, molecular studies or any other ancillary investigations. The concept of categorisation by 'clinicopathological entities' defined by clinical features, morphology, immunophenotype and more recently, genotype, began with the Kiel, and Lukes and Collins classifications in the late 1970s, becoming fully expressed in the REAL and subsequently WHO classifications. The current, multidisciplinary approach to categorisation adds significantly to the task facing the anatomical pathologist, since it requires distribution of biopsy material to all the appropriate specialised laboratories, the gathering of a range of cross-disciplinary information, the correlation of all diagnostic findings, deduction of a definitive diagnosis and, finally, integration of all the above into a single multiparameter report. In this review, we summarise the contemporary approach to the biopsy, diagnosis and reporting of lymphoproliferative disorders.
Ellis
David W
DW
Anatomical Pathology, Flinders Medical Centre and Gribbles Pathology, Adelaide, South Australia. dwe@bigpond.com
Eaton
Michael
M
Fox
Richard M
RM
Juneja
Surender
S
Leong
Anthony S-Y
AS
Miliauskas
John
J
Norris
Debra L
DL
Spagnolo
Dominic
D
Turner
Jenny
J
D003663:Decision Trees; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008232:Lymphoproliferative Disorders / Q000145:classification / Q000473:pathology*; D008297:Male; D010338:Pathology, Clinical / Q000379:methods*; D014944:World Health Organization